NSEGeneral Updates4d ago · 4 Aug 2026, 03:44 pm
General Updates
Omkar Speciality Chemicals Limited · OMKARCHEM
✦ AI SummaryResults
Omkar Speciality Chemicals Limited has informed the Exchange about General Updates regarding a Board Meeting to consider and approve unaudited and audited financial statements for the years 2022-2025, following the company's Corporate Insolvency Resolution Process under the Insolvency and Bankruptcy Code, 2016.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk2/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Omkar Speciality Chemicals Limited has informed the Exchange about General Updates
Attachments (1)
📄pdf
Download →
OMKARCHEM_04082026153857_Intimation.pdf
View document text
OMKAR SPECIALITY CHEMICALS LIMITED
Registered Office:- INNOVS Boston House CTS 261, 7th Floor, Boston House Suren Road, Village Gundavli Next to
Cinemax Cinema Mumbai- 400093, CIN: L24110MH2005PLC151589
OMIKERR Email:- omkar @kshitijpolyline.co.in Web:- www.omkarchemcicals.com Mobile:+-91 90818 72449
Always the leaders
Date: 04/08/2026
The Bombay Stock Exchange Limited The National Stock Exchange Limited
Corporate Relationship Department, Exchange Plaza, Bandra - Kurla Complex,
1st Floor, New Trading Ring, P] Tower, Bandra East, Mumbai - 400 059
Dalal Street, Mumbai - 400 001
Script Code: 533317 NSE Symbol: OMKARCHEM
Script Name: OMKARCHEM
Subject: Prior Intimation under Regulation 29 of the Securities and Exchange Board of India (Listin;
Obligations and Disclosure Requirements) Regulations, 2015
Dear Sir/Madam,
Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015, we hereby inform that the meeting of Board of Directors of the company will be
held on Friday, August 07,2026 to consider and approve the following matter:
1. Unaudited Financial Statements of the Company for the quarter September-2022, December 2022 and
Audited Financial Statements for the year ended on March 31, 2023.
2. Unaudited Financial Statements of the Company for all the quarter and Audited Financial Statements for the
year ended on March 31, 2024.
3. Unaudited Financial Statements of the Company for all the quarter and Audited Financial Statements for the
year ended on March 31, 2025.
As the exchange is aware that the company was under Corporate Insolvency Resolution Process under the provisions
of Insolvency and Bankruptcy Code, 2016, the company was not able to submit its Quarterly/Half Yearly/Yearly
financial results from the financial year 2022 to 2025. The delay was primarily attributable to circumstances
prevailing during the CIRP, including, inter alia, resignation of Key Managerial Personnel, non-availability of records
and other operational constraints.
Please be informed that tradingin the equity shares of the Company has remained suspended on BSE Limited and the
National Stock Exchange of India Limited. In view of the continuing suspension of trading, the Company has not issued
a separate intimation regarding the closure of the Trading Window in connection with the aforesaid Board Meeting,
as the securities of the Company are presently not available for trading on the Stock Exchanges.
This is for your information and records.
Thanking you,
Yours Faithfully,
For OmKar Speciality Chemicals Limited
MAHENDRA n2ievs os
Date: 20260808
KUMARJAIN 353350
Mahendra Kumar Jain
Additional Director
DIN: 09765526